Skip to content
PeptideAgent

Clinics in Mississippi

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What Mississippi law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Mississippi at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving Mississippi

No verified clinics serving Mississippi are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Mississippi

Yes. A Mississippi resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Mississippi-licensed physician, including by telemedicine under the Board of Medical Licensure's telemedicine rule (Miss. Admin. Code Title 30, Part 2635, Chapter 5), which requires a Mississippi license and a valid physician-patient relationship. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy permitted by the Mississippi Board of Pharmacy; out-of-state pharmacies need a nonresident permit under Miss. Code section 73-21-106 and must use a pharmacist-in-charge who also holds a Mississippi pharmacist license. The Board has issued guidance rejecting compounded semaglutide made from salt forms. [1] [2] [3] [4] [5] [6] [7] [8]

Compounded GLP-1 access in Mississippi

A telehealth GLP-1 program must use a Mississippi-licensed physician and a pharmacy holding a Mississippi permit or nonresident permit. [4] [7] [9]

Research use only sellers in Mississippi

The Mississippi Pharmacy Practice Act limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners, so sellers of "research use only" injectable peptides to Mississippi consumers are not lawful dispensers in the state. On August 19, 2026 the Mississippi State Board of Medical Licensure, Board of Nursing, and Board of Pharmacy issued a joint statement that no healthcare provider may compound, administer, dispense, prescribe, advise on, recommend, or supply a non-FDA-approved or research-grade peptide, or delegate those acts to another provider. The boards said a patient consent form calling a product research grade does not remove the provider's professional or legal liability, and providers must buy all prescription products, drugs, and ingredients from entities permitted by the Mississippi Board of Pharmacy. [1] [10] [11]

Mississippi notes on specific peptides

  • Semaglutide: Available branded by prescription from a Mississippi-licensed physician, including by telemedicine. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025, and the Mississippi Board of Pharmacy has said salt forms such as semaglutide sodium or acetate may not be used. [7] [9]

How to check a clinic in Mississippi

  1. Confirm the prescribing clinician's license with the Mississippi medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Mississippi Board of Pharmacy license lookup. [1] [4] [5] [6] [7] [8]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Mississippi. [1] [10] [11]

Common questions in Mississippi

Can I get a GLP-1 prescription in Mississippi through telemedicine?

Yes, from a physician with a Mississippi license who establishes a valid physician-patient relationship under the Board of Medical Licensure's telemedicine rule. Semaglutide and tirzepatide are not controlled substances. [3]

Can an out-of-state telehealth doctor treat me in Mississippi?

Only if the physician holds a valid Mississippi license. The Board's telemedicine rule limits telemedicine with Mississippi patients to Mississippi licensees. [2] [3]

All peptide legal questions for Mississippi

Sources

  1. [1]Mississippi Board of Pharmacy
  2. [2]Mississippi State Board of Medical Licensure: administrative code (June 2025 compilation)
  3. [3]Miss. Admin. Code Title 30, Part 2635, Chapter 5, Practice of telemedicine (rule 5.1 definitions)
  4. [4]Miss. Code section 73-21-106, Registration requirement for nonresident pharmacies
  5. [5]Mississippi House Bill 856, 2025 Regular Session (as sent to Governor): reenacts section 73-21-106 and extends the Pharmacy Practice Act repealer to July 1, 2029
  6. [6]Mississippi Pharmacy Practice Regulations (Title 30, Part 3001)
  7. [7]Mississippi Board of Pharmacy: semaglutide compounding guidance
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  10. [10]21 U.S.C. 331, Prohibited acts
  11. [11]Joint Statement Concerning the Prescribing of Non-FDA Approved (Research-Grade) Peptides (Mississippi Board of Nursing, Board of Pharmacy, State Board of Medical Licensure, August 19, 2026)